Explore the latest analyses of pharma company action
The 2021 Access to Medicine Index uses 33 metrics to examine how 20 pharmaceutical companies respond to the need for better access to medicine in 106 low- and middle-income countries and for 82 diseases, conditions and pathogens. Here are the results.